Global Rapid test devices Market
Global Rapid test devices Market

Rapid test devices Comprehensive Study by Application (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Drugs-of-Abuse Testing, Fertility, Pregnancy Testing, Others), Technology (Lateral Flow Assays, Flow-Through, Agglutination, Solid Phase), End-User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Others) Players and Region - Global Market Outlook to 2026

Rapid test devices Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 235 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Rapid test devices Market Scope?
The demand within the global market for fast tests has been rising on account of the recognition of preliminary screening across medical facilities. The necessity for diagnostic tests across varied domains at intervals health care has created commendable growth opportunities within the global market for the rapid tests. Rapid tests, in essence, refer to tests that may be used throughout emergencies at medical facilities or for home-care treatments. The foremost distinctive characteristic of this way of testing is that the restricted use of resources and therefore the simplicity of execution. Hence, it's safe to say that the demand dynamics of the global marketplace for rapid testing would considerably improve within the years to come. The medical fraternity has adopted fast testing as a method to boost the general performance of the business. Considering the aforementioned factors, it will be safely explicit that the world market for rapid testing would grow at a swift pace within the years to come. Moreover, the concerted efforts of the vendors within the global market for rapid testing shall conjointly aid the expansion of the overall market.

The Rapid test devices market study is being classified, by Application (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Drugs-of-Abuse Testing, Fertility, Pregnancy Testing and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Rapid test devices market throughout the predicted period.

F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Siemens Healthcare Private Limited (Germany), Crunchbase Inc. (United States), Atlas Link,Inc (United States), Akers Biosciences, Inc. (United States), Bio-Rad Laboratories, Inc (United States), Cepheid (United States), Hologic, Inc (United States), OraSure Technologies, Inc (United States), Quidel Corporation (United States) and ACON Laboratories, Inc (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Creative Diagnostics. (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Rapid test devices market by Type, Application and Region.

On the basis of geography, the market of Rapid test devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing Adoption Due to The Outbreak of Covid – 19

Market Drivers
  • Increasing Demand of The Home-Based POC Diagnostic Kits
  • Increasing Need for Quick and Better Results

Opportunities
  • Technological Advancements & Modernization on A Rapid Growth Rate

Restraints
  • High Cost of The Kits
  • Fluctuating Price of Raw Materials

Challenges
  • Failure to Eliminate the Need for Microscopy Diagnosis
  • Lack of Awareness Regarding Newer Rapid Diagnostic Tests


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Rapid test devices, Suppliers and Distributors of Rapid test devices, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Rapid test devices market expands?
The Global Rapid test devices market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Rapid test devices market?
The prominent players of Global Rapid test devices market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Siemens Healthcare Private Limited (Germany), Crunchbase Inc. (United States), Atlas Link,Inc (United States), Akers Biosciences, Inc. (United States), Bio-Rad Laboratories, Inc (United States), Cepheid (United States), Hologic, Inc (United States), OraSure Technologies, Inc (United States), Quidel Corporation (United States) and ACON Laboratories, Inc (United States), to name a few.

3. What are the top priorities to focus for Rapid test devices market’s growth?
In this highly competitive & fast evolving Rapid test devices industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Application
  • Glucose Monitoring
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Drugs-of-Abuse Testing
  • Fertility
  • Pregnancy Testing
  • Others
By Technology
  • Lateral Flow Assays
  • Flow-Through
  • Agglutination
  • Solid Phase

By End-User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand of The Home-Based POC Diagnostic Kits
      • 3.2.2. Increasing Need for Quick and Better Results
    • 3.3. Market Challenges
      • 3.3.1. Failure to Eliminate the Need for Microscopy Diagnosis
      • 3.3.2. Lack of Awareness Regarding Newer Rapid Diagnostic Tests
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption Due to The Outbreak of Covid – 19
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rapid test devices, by Application, Technology, End-User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Rapid test devices (Value)
      • 5.2.1. Global Rapid test devices by: Application (Value)
        • 5.2.1.1. Glucose Monitoring
        • 5.2.1.2. Cardiometabolic Testing
        • 5.2.1.3. Infectious Disease Testing
        • 5.2.1.4. Drugs-of-Abuse Testing
        • 5.2.1.5. Fertility
        • 5.2.1.6. Pregnancy Testing
        • 5.2.1.7. Others
      • 5.2.2. Global Rapid test devices by: Technology (Value)
        • 5.2.2.1. Lateral Flow Assays
        • 5.2.2.2. Flow-Through
        • 5.2.2.3. Agglutination
        • 5.2.2.4. Solid Phase
      • 5.2.3. Global Rapid test devices by: End-User (Value)
        • 5.2.3.1. Hospitals and Clinics
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Home Care Settings
        • 5.2.3.4. Others
      • 5.2.4. Global Rapid test devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Rapid test devices (Volume)
      • 5.3.1. Global Rapid test devices by: Application (Volume)
        • 5.3.1.1. Glucose Monitoring
        • 5.3.1.2. Cardiometabolic Testing
        • 5.3.1.3. Infectious Disease Testing
        • 5.3.1.4. Drugs-of-Abuse Testing
        • 5.3.1.5. Fertility
        • 5.3.1.6. Pregnancy Testing
        • 5.3.1.7. Others
      • 5.3.2. Global Rapid test devices by: Technology (Volume)
        • 5.3.2.1. Lateral Flow Assays
        • 5.3.2.2. Flow-Through
        • 5.3.2.3. Agglutination
        • 5.3.2.4. Solid Phase
      • 5.3.3. Global Rapid test devices by: End-User (Volume)
        • 5.3.3.1. Hospitals and Clinics
        • 5.3.3.2. Diagnostic Laboratories
        • 5.3.3.3. Home Care Settings
        • 5.3.3.4. Others
      • 5.3.4. Global Rapid test devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Rapid test devices (Price)
  • 6. Rapid test devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthcare Private Limited (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Crunchbase Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Atlas Link,Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Akers Biosciences, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories, Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cepheid (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hologic, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. OraSure Technologies, Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Quidel Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. ACON Laboratories, Inc (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Rapid test devices Sale, by Application, Technology, End-User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Rapid test devices (Value)
      • 7.2.1. Global Rapid test devices by: Application (Value)
        • 7.2.1.1. Glucose Monitoring
        • 7.2.1.2. Cardiometabolic Testing
        • 7.2.1.3. Infectious Disease Testing
        • 7.2.1.4. Drugs-of-Abuse Testing
        • 7.2.1.5. Fertility
        • 7.2.1.6. Pregnancy Testing
        • 7.2.1.7. Others
      • 7.2.2. Global Rapid test devices by: Technology (Value)
        • 7.2.2.1. Lateral Flow Assays
        • 7.2.2.2. Flow-Through
        • 7.2.2.3. Agglutination
        • 7.2.2.4. Solid Phase
      • 7.2.3. Global Rapid test devices by: End-User (Value)
        • 7.2.3.1. Hospitals and Clinics
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Home Care Settings
        • 7.2.3.4. Others
      • 7.2.4. Global Rapid test devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Rapid test devices (Volume)
      • 7.3.1. Global Rapid test devices by: Application (Volume)
        • 7.3.1.1. Glucose Monitoring
        • 7.3.1.2. Cardiometabolic Testing
        • 7.3.1.3. Infectious Disease Testing
        • 7.3.1.4. Drugs-of-Abuse Testing
        • 7.3.1.5. Fertility
        • 7.3.1.6. Pregnancy Testing
        • 7.3.1.7. Others
      • 7.3.2. Global Rapid test devices by: Technology (Volume)
        • 7.3.2.1. Lateral Flow Assays
        • 7.3.2.2. Flow-Through
        • 7.3.2.3. Agglutination
        • 7.3.2.4. Solid Phase
      • 7.3.3. Global Rapid test devices by: End-User (Volume)
        • 7.3.3.1. Hospitals and Clinics
        • 7.3.3.2. Diagnostic Laboratories
        • 7.3.3.3. Home Care Settings
        • 7.3.3.4. Others
      • 7.3.4. Global Rapid test devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Rapid test devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rapid test devices: by Application(USD Million)
  • Table 2. Rapid test devices Glucose Monitoring , by Region USD Million (2015-2020)
  • Table 3. Rapid test devices Cardiometabolic Testing , by Region USD Million (2015-2020)
  • Table 4. Rapid test devices Infectious Disease Testing , by Region USD Million (2015-2020)
  • Table 5. Rapid test devices Drugs-of-Abuse Testing , by Region USD Million (2015-2020)
  • Table 6. Rapid test devices Fertility , by Region USD Million (2015-2020)
  • Table 7. Rapid test devices Pregnancy Testing , by Region USD Million (2015-2020)
  • Table 8. Rapid test devices Others , by Region USD Million (2015-2020)
  • Table 9. Rapid test devices: by Technology(USD Million)
  • Table 10. Rapid test devices Lateral Flow Assays , by Region USD Million (2015-2020)
  • Table 11. Rapid test devices Flow-Through , by Region USD Million (2015-2020)
  • Table 12. Rapid test devices Agglutination , by Region USD Million (2015-2020)
  • Table 13. Rapid test devices Solid Phase , by Region USD Million (2015-2020)
  • Table 14. Rapid test devices: by End-User(USD Million)
  • Table 15. Rapid test devices Hospitals and Clinics , by Region USD Million (2015-2020)
  • Table 16. Rapid test devices Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 17. Rapid test devices Home Care Settings , by Region USD Million (2015-2020)
  • Table 18. Rapid test devices Others , by Region USD Million (2015-2020)
  • Table 19. South America Rapid test devices, by Country USD Million (2015-2020)
  • Table 20. South America Rapid test devices, by Application USD Million (2015-2020)
  • Table 21. South America Rapid test devices, by Technology USD Million (2015-2020)
  • Table 22. South America Rapid test devices, by End-User USD Million (2015-2020)
  • Table 23. Brazil Rapid test devices, by Application USD Million (2015-2020)
  • Table 24. Brazil Rapid test devices, by Technology USD Million (2015-2020)
  • Table 25. Brazil Rapid test devices, by End-User USD Million (2015-2020)
  • Table 26. Argentina Rapid test devices, by Application USD Million (2015-2020)
  • Table 27. Argentina Rapid test devices, by Technology USD Million (2015-2020)
  • Table 28. Argentina Rapid test devices, by End-User USD Million (2015-2020)
  • Table 29. Rest of South America Rapid test devices, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Rapid test devices, by Technology USD Million (2015-2020)
  • Table 31. Rest of South America Rapid test devices, by End-User USD Million (2015-2020)
  • Table 32. Asia Pacific Rapid test devices, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Rapid test devices, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Rapid test devices, by Technology USD Million (2015-2020)
  • Table 35. Asia Pacific Rapid test devices, by End-User USD Million (2015-2020)
  • Table 36. China Rapid test devices, by Application USD Million (2015-2020)
  • Table 37. China Rapid test devices, by Technology USD Million (2015-2020)
  • Table 38. China Rapid test devices, by End-User USD Million (2015-2020)
  • Table 39. Japan Rapid test devices, by Application USD Million (2015-2020)
  • Table 40. Japan Rapid test devices, by Technology USD Million (2015-2020)
  • Table 41. Japan Rapid test devices, by End-User USD Million (2015-2020)
  • Table 42. India Rapid test devices, by Application USD Million (2015-2020)
  • Table 43. India Rapid test devices, by Technology USD Million (2015-2020)
  • Table 44. India Rapid test devices, by End-User USD Million (2015-2020)
  • Table 45. South Korea Rapid test devices, by Application USD Million (2015-2020)
  • Table 46. South Korea Rapid test devices, by Technology USD Million (2015-2020)
  • Table 47. South Korea Rapid test devices, by End-User USD Million (2015-2020)
  • Table 48. Taiwan Rapid test devices, by Application USD Million (2015-2020)
  • Table 49. Taiwan Rapid test devices, by Technology USD Million (2015-2020)
  • Table 50. Taiwan Rapid test devices, by End-User USD Million (2015-2020)
  • Table 51. Australia Rapid test devices, by Application USD Million (2015-2020)
  • Table 52. Australia Rapid test devices, by Technology USD Million (2015-2020)
  • Table 53. Australia Rapid test devices, by End-User USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Rapid test devices, by Application USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Rapid test devices, by Technology USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Rapid test devices, by End-User USD Million (2015-2020)
  • Table 57. Europe Rapid test devices, by Country USD Million (2015-2020)
  • Table 58. Europe Rapid test devices, by Application USD Million (2015-2020)
  • Table 59. Europe Rapid test devices, by Technology USD Million (2015-2020)
  • Table 60. Europe Rapid test devices, by End-User USD Million (2015-2020)
  • Table 61. Germany Rapid test devices, by Application USD Million (2015-2020)
  • Table 62. Germany Rapid test devices, by Technology USD Million (2015-2020)
  • Table 63. Germany Rapid test devices, by End-User USD Million (2015-2020)
  • Table 64. France Rapid test devices, by Application USD Million (2015-2020)
  • Table 65. France Rapid test devices, by Technology USD Million (2015-2020)
  • Table 66. France Rapid test devices, by End-User USD Million (2015-2020)
  • Table 67. Italy Rapid test devices, by Application USD Million (2015-2020)
  • Table 68. Italy Rapid test devices, by Technology USD Million (2015-2020)
  • Table 69. Italy Rapid test devices, by End-User USD Million (2015-2020)
  • Table 70. United Kingdom Rapid test devices, by Application USD Million (2015-2020)
  • Table 71. United Kingdom Rapid test devices, by Technology USD Million (2015-2020)
  • Table 72. United Kingdom Rapid test devices, by End-User USD Million (2015-2020)
  • Table 73. Netherlands Rapid test devices, by Application USD Million (2015-2020)
  • Table 74. Netherlands Rapid test devices, by Technology USD Million (2015-2020)
  • Table 75. Netherlands Rapid test devices, by End-User USD Million (2015-2020)
  • Table 76. Rest of Europe Rapid test devices, by Application USD Million (2015-2020)
  • Table 77. Rest of Europe Rapid test devices, by Technology USD Million (2015-2020)
  • Table 78. Rest of Europe Rapid test devices, by End-User USD Million (2015-2020)
  • Table 79. MEA Rapid test devices, by Country USD Million (2015-2020)
  • Table 80. MEA Rapid test devices, by Application USD Million (2015-2020)
  • Table 81. MEA Rapid test devices, by Technology USD Million (2015-2020)
  • Table 82. MEA Rapid test devices, by End-User USD Million (2015-2020)
  • Table 83. Middle East Rapid test devices, by Application USD Million (2015-2020)
  • Table 84. Middle East Rapid test devices, by Technology USD Million (2015-2020)
  • Table 85. Middle East Rapid test devices, by End-User USD Million (2015-2020)
  • Table 86. Africa Rapid test devices, by Application USD Million (2015-2020)
  • Table 87. Africa Rapid test devices, by Technology USD Million (2015-2020)
  • Table 88. Africa Rapid test devices, by End-User USD Million (2015-2020)
  • Table 89. North America Rapid test devices, by Country USD Million (2015-2020)
  • Table 90. North America Rapid test devices, by Application USD Million (2015-2020)
  • Table 91. North America Rapid test devices, by Technology USD Million (2015-2020)
  • Table 92. North America Rapid test devices, by End-User USD Million (2015-2020)
  • Table 93. United States Rapid test devices, by Application USD Million (2015-2020)
  • Table 94. United States Rapid test devices, by Technology USD Million (2015-2020)
  • Table 95. United States Rapid test devices, by End-User USD Million (2015-2020)
  • Table 96. Canada Rapid test devices, by Application USD Million (2015-2020)
  • Table 97. Canada Rapid test devices, by Technology USD Million (2015-2020)
  • Table 98. Canada Rapid test devices, by End-User USD Million (2015-2020)
  • Table 99. Mexico Rapid test devices, by Application USD Million (2015-2020)
  • Table 100. Mexico Rapid test devices, by Technology USD Million (2015-2020)
  • Table 101. Mexico Rapid test devices, by End-User USD Million (2015-2020)
  • Table 102. Rapid test devices Sales: by Application(K Units)
  • Table 103. Rapid test devices Sales Glucose Monitoring , by Region K Units (2015-2020)
  • Table 104. Rapid test devices Sales Cardiometabolic Testing , by Region K Units (2015-2020)
  • Table 105. Rapid test devices Sales Infectious Disease Testing , by Region K Units (2015-2020)
  • Table 106. Rapid test devices Sales Drugs-of-Abuse Testing , by Region K Units (2015-2020)
  • Table 107. Rapid test devices Sales Fertility , by Region K Units (2015-2020)
  • Table 108. Rapid test devices Sales Pregnancy Testing , by Region K Units (2015-2020)
  • Table 109. Rapid test devices Sales Others , by Region K Units (2015-2020)
  • Table 110. Rapid test devices Sales: by Technology(K Units)
  • Table 111. Rapid test devices Sales Lateral Flow Assays , by Region K Units (2015-2020)
  • Table 112. Rapid test devices Sales Flow-Through , by Region K Units (2015-2020)
  • Table 113. Rapid test devices Sales Agglutination , by Region K Units (2015-2020)
  • Table 114. Rapid test devices Sales Solid Phase , by Region K Units (2015-2020)
  • Table 115. Rapid test devices Sales: by End-User(K Units)
  • Table 116. Rapid test devices Sales Hospitals and Clinics , by Region K Units (2015-2020)
  • Table 117. Rapid test devices Sales Diagnostic Laboratories , by Region K Units (2015-2020)
  • Table 118. Rapid test devices Sales Home Care Settings , by Region K Units (2015-2020)
  • Table 119. Rapid test devices Sales Others , by Region K Units (2015-2020)
  • Table 120. South America Rapid test devices Sales, by Country K Units (2015-2020)
  • Table 121. South America Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 122. South America Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 123. South America Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 124. Brazil Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 125. Brazil Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 126. Brazil Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 127. Argentina Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 128. Argentina Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 129. Argentina Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 130. Rest of South America Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 131. Rest of South America Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 132. Rest of South America Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 133. Asia Pacific Rapid test devices Sales, by Country K Units (2015-2020)
  • Table 134. Asia Pacific Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 135. Asia Pacific Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 136. Asia Pacific Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 137. China Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 138. China Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 139. China Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 140. Japan Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 141. Japan Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 142. Japan Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 143. India Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 144. India Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 145. India Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 146. South Korea Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 147. South Korea Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 148. South Korea Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 149. Taiwan Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 150. Taiwan Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 151. Taiwan Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 152. Australia Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 153. Australia Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 154. Australia Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 155. Rest of Asia-Pacific Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 156. Rest of Asia-Pacific Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 157. Rest of Asia-Pacific Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 158. Europe Rapid test devices Sales, by Country K Units (2015-2020)
  • Table 159. Europe Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 160. Europe Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 161. Europe Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 162. Germany Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 163. Germany Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 164. Germany Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 165. France Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 166. France Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 167. France Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 168. Italy Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 169. Italy Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 170. Italy Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 171. United Kingdom Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 172. United Kingdom Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 173. United Kingdom Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 174. Netherlands Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 175. Netherlands Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 176. Netherlands Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 177. Rest of Europe Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 178. Rest of Europe Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 179. Rest of Europe Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 180. MEA Rapid test devices Sales, by Country K Units (2015-2020)
  • Table 181. MEA Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 182. MEA Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 183. MEA Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 184. Middle East Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 185. Middle East Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 186. Middle East Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 187. Africa Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 188. Africa Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 189. Africa Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 190. North America Rapid test devices Sales, by Country K Units (2015-2020)
  • Table 191. North America Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 192. North America Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 193. North America Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 194. United States Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 195. United States Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 196. United States Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 197. Canada Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 198. Canada Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 199. Canada Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 200. Mexico Rapid test devices Sales, by Application K Units (2015-2020)
  • Table 201. Mexico Rapid test devices Sales, by Technology K Units (2015-2020)
  • Table 202. Mexico Rapid test devices Sales, by End-User K Units (2015-2020)
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Rapid test devices: by Application(USD Million)
  • Table 216. Rapid test devices Glucose Monitoring , by Region USD Million (2021-2026)
  • Table 217. Rapid test devices Cardiometabolic Testing , by Region USD Million (2021-2026)
  • Table 218. Rapid test devices Infectious Disease Testing , by Region USD Million (2021-2026)
  • Table 219. Rapid test devices Drugs-of-Abuse Testing , by Region USD Million (2021-2026)
  • Table 220. Rapid test devices Fertility , by Region USD Million (2021-2026)
  • Table 221. Rapid test devices Pregnancy Testing , by Region USD Million (2021-2026)
  • Table 222. Rapid test devices Others , by Region USD Million (2021-2026)
  • Table 223. Rapid test devices: by Technology(USD Million)
  • Table 224. Rapid test devices Lateral Flow Assays , by Region USD Million (2021-2026)
  • Table 225. Rapid test devices Flow-Through , by Region USD Million (2021-2026)
  • Table 226. Rapid test devices Agglutination , by Region USD Million (2021-2026)
  • Table 227. Rapid test devices Solid Phase , by Region USD Million (2021-2026)
  • Table 228. Rapid test devices: by End-User(USD Million)
  • Table 229. Rapid test devices Hospitals and Clinics , by Region USD Million (2021-2026)
  • Table 230. Rapid test devices Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 231. Rapid test devices Home Care Settings , by Region USD Million (2021-2026)
  • Table 232. Rapid test devices Others , by Region USD Million (2021-2026)
  • Table 233. South America Rapid test devices, by Country USD Million (2021-2026)
  • Table 234. South America Rapid test devices, by Application USD Million (2021-2026)
  • Table 235. South America Rapid test devices, by Technology USD Million (2021-2026)
  • Table 236. South America Rapid test devices, by End-User USD Million (2021-2026)
  • Table 237. Brazil Rapid test devices, by Application USD Million (2021-2026)
  • Table 238. Brazil Rapid test devices, by Technology USD Million (2021-2026)
  • Table 239. Brazil Rapid test devices, by End-User USD Million (2021-2026)
  • Table 240. Argentina Rapid test devices, by Application USD Million (2021-2026)
  • Table 241. Argentina Rapid test devices, by Technology USD Million (2021-2026)
  • Table 242. Argentina Rapid test devices, by End-User USD Million (2021-2026)
  • Table 243. Rest of South America Rapid test devices, by Application USD Million (2021-2026)
  • Table 244. Rest of South America Rapid test devices, by Technology USD Million (2021-2026)
  • Table 245. Rest of South America Rapid test devices, by End-User USD Million (2021-2026)
  • Table 246. Asia Pacific Rapid test devices, by Country USD Million (2021-2026)
  • Table 247. Asia Pacific Rapid test devices, by Application USD Million (2021-2026)
  • Table 248. Asia Pacific Rapid test devices, by Technology USD Million (2021-2026)
  • Table 249. Asia Pacific Rapid test devices, by End-User USD Million (2021-2026)
  • Table 250. China Rapid test devices, by Application USD Million (2021-2026)
  • Table 251. China Rapid test devices, by Technology USD Million (2021-2026)
  • Table 252. China Rapid test devices, by End-User USD Million (2021-2026)
  • Table 253. Japan Rapid test devices, by Application USD Million (2021-2026)
  • Table 254. Japan Rapid test devices, by Technology USD Million (2021-2026)
  • Table 255. Japan Rapid test devices, by End-User USD Million (2021-2026)
  • Table 256. India Rapid test devices, by Application USD Million (2021-2026)
  • Table 257. India Rapid test devices, by Technology USD Million (2021-2026)
  • Table 258. India Rapid test devices, by End-User USD Million (2021-2026)
  • Table 259. South Korea Rapid test devices, by Application USD Million (2021-2026)
  • Table 260. South Korea Rapid test devices, by Technology USD Million (2021-2026)
  • Table 261. South Korea Rapid test devices, by End-User USD Million (2021-2026)
  • Table 262. Taiwan Rapid test devices, by Application USD Million (2021-2026)
  • Table 263. Taiwan Rapid test devices, by Technology USD Million (2021-2026)
  • Table 264. Taiwan Rapid test devices, by End-User USD Million (2021-2026)
  • Table 265. Australia Rapid test devices, by Application USD Million (2021-2026)
  • Table 266. Australia Rapid test devices, by Technology USD Million (2021-2026)
  • Table 267. Australia Rapid test devices, by End-User USD Million (2021-2026)
  • Table 268. Rest of Asia-Pacific Rapid test devices, by Application USD Million (2021-2026)
  • Table 269. Rest of Asia-Pacific Rapid test devices, by Technology USD Million (2021-2026)
  • Table 270. Rest of Asia-Pacific Rapid test devices, by End-User USD Million (2021-2026)
  • Table 271. Europe Rapid test devices, by Country USD Million (2021-2026)
  • Table 272. Europe Rapid test devices, by Application USD Million (2021-2026)
  • Table 273. Europe Rapid test devices, by Technology USD Million (2021-2026)
  • Table 274. Europe Rapid test devices, by End-User USD Million (2021-2026)
  • Table 275. Germany Rapid test devices, by Application USD Million (2021-2026)
  • Table 276. Germany Rapid test devices, by Technology USD Million (2021-2026)
  • Table 277. Germany Rapid test devices, by End-User USD Million (2021-2026)
  • Table 278. France Rapid test devices, by Application USD Million (2021-2026)
  • Table 279. France Rapid test devices, by Technology USD Million (2021-2026)
  • Table 280. France Rapid test devices, by End-User USD Million (2021-2026)
  • Table 281. Italy Rapid test devices, by Application USD Million (2021-2026)
  • Table 282. Italy Rapid test devices, by Technology USD Million (2021-2026)
  • Table 283. Italy Rapid test devices, by End-User USD Million (2021-2026)
  • Table 284. United Kingdom Rapid test devices, by Application USD Million (2021-2026)
  • Table 285. United Kingdom Rapid test devices, by Technology USD Million (2021-2026)
  • Table 286. United Kingdom Rapid test devices, by End-User USD Million (2021-2026)
  • Table 287. Netherlands Rapid test devices, by Application USD Million (2021-2026)
  • Table 288. Netherlands Rapid test devices, by Technology USD Million (2021-2026)
  • Table 289. Netherlands Rapid test devices, by End-User USD Million (2021-2026)
  • Table 290. Rest of Europe Rapid test devices, by Application USD Million (2021-2026)
  • Table 291. Rest of Europe Rapid test devices, by Technology USD Million (2021-2026)
  • Table 292. Rest of Europe Rapid test devices, by End-User USD Million (2021-2026)
  • Table 293. MEA Rapid test devices, by Country USD Million (2021-2026)
  • Table 294. MEA Rapid test devices, by Application USD Million (2021-2026)
  • Table 295. MEA Rapid test devices, by Technology USD Million (2021-2026)
  • Table 296. MEA Rapid test devices, by End-User USD Million (2021-2026)
  • Table 297. Middle East Rapid test devices, by Application USD Million (2021-2026)
  • Table 298. Middle East Rapid test devices, by Technology USD Million (2021-2026)
  • Table 299. Middle East Rapid test devices, by End-User USD Million (2021-2026)
  • Table 300. Africa Rapid test devices, by Application USD Million (2021-2026)
  • Table 301. Africa Rapid test devices, by Technology USD Million (2021-2026)
  • Table 302. Africa Rapid test devices, by End-User USD Million (2021-2026)
  • Table 303. North America Rapid test devices, by Country USD Million (2021-2026)
  • Table 304. North America Rapid test devices, by Application USD Million (2021-2026)
  • Table 305. North America Rapid test devices, by Technology USD Million (2021-2026)
  • Table 306. North America Rapid test devices, by End-User USD Million (2021-2026)
  • Table 307. United States Rapid test devices, by Application USD Million (2021-2026)
  • Table 308. United States Rapid test devices, by Technology USD Million (2021-2026)
  • Table 309. United States Rapid test devices, by End-User USD Million (2021-2026)
  • Table 310. Canada Rapid test devices, by Application USD Million (2021-2026)
  • Table 311. Canada Rapid test devices, by Technology USD Million (2021-2026)
  • Table 312. Canada Rapid test devices, by End-User USD Million (2021-2026)
  • Table 313. Mexico Rapid test devices, by Application USD Million (2021-2026)
  • Table 314. Mexico Rapid test devices, by Technology USD Million (2021-2026)
  • Table 315. Mexico Rapid test devices, by End-User USD Million (2021-2026)
  • Table 316. Rapid test devices Sales: by Application(K Units)
  • Table 317. Rapid test devices Sales Glucose Monitoring , by Region K Units (2021-2026)
  • Table 318. Rapid test devices Sales Cardiometabolic Testing , by Region K Units (2021-2026)
  • Table 319. Rapid test devices Sales Infectious Disease Testing , by Region K Units (2021-2026)
  • Table 320. Rapid test devices Sales Drugs-of-Abuse Testing , by Region K Units (2021-2026)
  • Table 321. Rapid test devices Sales Fertility , by Region K Units (2021-2026)
  • Table 322. Rapid test devices Sales Pregnancy Testing , by Region K Units (2021-2026)
  • Table 323. Rapid test devices Sales Others , by Region K Units (2021-2026)
  • Table 324. Rapid test devices Sales: by Technology(K Units)
  • Table 325. Rapid test devices Sales Lateral Flow Assays , by Region K Units (2021-2026)
  • Table 326. Rapid test devices Sales Flow-Through , by Region K Units (2021-2026)
  • Table 327. Rapid test devices Sales Agglutination , by Region K Units (2021-2026)
  • Table 328. Rapid test devices Sales Solid Phase , by Region K Units (2021-2026)
  • Table 329. Rapid test devices Sales: by End-User(K Units)
  • Table 330. Rapid test devices Sales Hospitals and Clinics , by Region K Units (2021-2026)
  • Table 331. Rapid test devices Sales Diagnostic Laboratories , by Region K Units (2021-2026)
  • Table 332. Rapid test devices Sales Home Care Settings , by Region K Units (2021-2026)
  • Table 333. Rapid test devices Sales Others , by Region K Units (2021-2026)
  • Table 334. South America Rapid test devices Sales, by Country K Units (2021-2026)
  • Table 335. South America Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 336. South America Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 337. South America Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 338. Brazil Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 339. Brazil Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 340. Brazil Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 341. Argentina Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 342. Argentina Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 343. Argentina Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 344. Rest of South America Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 345. Rest of South America Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 346. Rest of South America Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 347. Asia Pacific Rapid test devices Sales, by Country K Units (2021-2026)
  • Table 348. Asia Pacific Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 349. Asia Pacific Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 350. Asia Pacific Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 351. China Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 352. China Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 353. China Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 354. Japan Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 355. Japan Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 356. Japan Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 357. India Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 358. India Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 359. India Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 360. South Korea Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 361. South Korea Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 362. South Korea Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 363. Taiwan Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 364. Taiwan Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 365. Taiwan Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 366. Australia Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 367. Australia Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 368. Australia Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 369. Rest of Asia-Pacific Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 370. Rest of Asia-Pacific Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 371. Rest of Asia-Pacific Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 372. Europe Rapid test devices Sales, by Country K Units (2021-2026)
  • Table 373. Europe Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 374. Europe Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 375. Europe Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 376. Germany Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 377. Germany Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 378. Germany Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 379. France Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 380. France Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 381. France Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 382. Italy Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 383. Italy Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 384. Italy Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 385. United Kingdom Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 386. United Kingdom Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 387. United Kingdom Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 388. Netherlands Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 389. Netherlands Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 390. Netherlands Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 391. Rest of Europe Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 392. Rest of Europe Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 393. Rest of Europe Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 394. MEA Rapid test devices Sales, by Country K Units (2021-2026)
  • Table 395. MEA Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 396. MEA Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 397. MEA Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 398. Middle East Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 399. Middle East Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 400. Middle East Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 401. Africa Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 402. Africa Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 403. Africa Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 404. North America Rapid test devices Sales, by Country K Units (2021-2026)
  • Table 405. North America Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 406. North America Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 407. North America Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 408. United States Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 409. United States Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 410. United States Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 411. Canada Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 412. Canada Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 413. Canada Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 414. Mexico Rapid test devices Sales, by Application K Units (2021-2026)
  • Table 415. Mexico Rapid test devices Sales, by Technology K Units (2021-2026)
  • Table 416. Mexico Rapid test devices Sales, by End-User K Units (2021-2026)
  • Table 417. Research Programs/Design for This Report
  • Table 418. Key Data Information from Secondary Sources
  • Table 419. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rapid test devices: by Application USD Million (2015-2020)
  • Figure 5. Global Rapid test devices: by Technology USD Million (2015-2020)
  • Figure 6. Global Rapid test devices: by End-User USD Million (2015-2020)
  • Figure 7. South America Rapid test devices Share (%), by Country
  • Figure 8. Asia Pacific Rapid test devices Share (%), by Country
  • Figure 9. Europe Rapid test devices Share (%), by Country
  • Figure 10. MEA Rapid test devices Share (%), by Country
  • Figure 11. North America Rapid test devices Share (%), by Country
  • Figure 12. Global Rapid test devices: by Application K Units (2015-2020)
  • Figure 13. Global Rapid test devices: by Technology K Units (2015-2020)
  • Figure 14. Global Rapid test devices: by End-User K Units (2015-2020)
  • Figure 15. South America Rapid test devices Share (%), by Country
  • Figure 16. Asia Pacific Rapid test devices Share (%), by Country
  • Figure 17. Europe Rapid test devices Share (%), by Country
  • Figure 18. MEA Rapid test devices Share (%), by Country
  • Figure 19. North America Rapid test devices Share (%), by Country
  • Figure 20. Global Rapid test devices share by Players 2020 (%)
  • Figure 21. Global Rapid test devices share by Players (Top 3) 2020(%)
  • Figure 22. Global Rapid test devices share by Players (Top 5) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2020
  • Figure 26. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 27. Abbott (United States) Revenue: by Geography 2020
  • Figure 28. Siemens Healthcare Private Limited (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Siemens Healthcare Private Limited (Germany) Revenue: by Geography 2020
  • Figure 30. Crunchbase Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Crunchbase Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Atlas Link,Inc (United States) Revenue, Net Income and Gross profit
  • Figure 33. Atlas Link,Inc (United States) Revenue: by Geography 2020
  • Figure 34. Akers Biosciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Akers Biosciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 36. Bio-Rad Laboratories, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 37. Bio-Rad Laboratories, Inc (United States) Revenue: by Geography 2020
  • Figure 38. Cepheid (United States) Revenue, Net Income and Gross profit
  • Figure 39. Cepheid (United States) Revenue: by Geography 2020
  • Figure 40. Hologic, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 41. Hologic, Inc (United States) Revenue: by Geography 2020
  • Figure 42. OraSure Technologies, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 43. OraSure Technologies, Inc (United States) Revenue: by Geography 2020
  • Figure 44. Quidel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 45. Quidel Corporation (United States) Revenue: by Geography 2020
  • Figure 46. ACON Laboratories, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 47. ACON Laboratories, Inc (United States) Revenue: by Geography 2020
  • Figure 48. Global Rapid test devices: by Application USD Million (2021-2026)
  • Figure 49. Global Rapid test devices: by Technology USD Million (2021-2026)
  • Figure 50. Global Rapid test devices: by End-User USD Million (2021-2026)
  • Figure 51. South America Rapid test devices Share (%), by Country
  • Figure 52. Asia Pacific Rapid test devices Share (%), by Country
  • Figure 53. Europe Rapid test devices Share (%), by Country
  • Figure 54. MEA Rapid test devices Share (%), by Country
  • Figure 55. North America Rapid test devices Share (%), by Country
  • Figure 56. Global Rapid test devices: by Application K Units (2021-2026)
  • Figure 57. Global Rapid test devices: by Technology K Units (2021-2026)
  • Figure 58. Global Rapid test devices: by End-User K Units (2021-2026)
  • Figure 59. South America Rapid test devices Share (%), by Country
  • Figure 60. Asia Pacific Rapid test devices Share (%), by Country
  • Figure 61. Europe Rapid test devices Share (%), by Country
  • Figure 62. MEA Rapid test devices Share (%), by Country
  • Figure 63. North America Rapid test devices Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Abbott (United States)
  • Siemens Healthcare Private Limited (Germany)
  • Crunchbase Inc. (United States)
  • Atlas Link,Inc (United States)
  • Akers Biosciences, Inc. (United States)
  • Bio-Rad Laboratories, Inc (United States)
  • Cepheid (United States)
  • Hologic, Inc (United States)
  • OraSure Technologies, Inc (United States)
  • Quidel Corporation (United States)
  • ACON Laboratories, Inc (United States)
Additional players considered in the study are as follows:
Creative Diagnostics. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation